Cangene (FRA:YGE) Other Long-Term Liabilities : €37.33 Mil (As of Oct. 2013)

View and export this data going back to . Start your Free Trial

What is Cangene Other Long-Term Liabilities?

Cangene's other long-term liabilities for the quarter that ended in Oct. 2013 was €37.33 Mil.

Cangene's quarterly other long-term liabilities declined from Apr. 2013 (€40.70 Mil) to Jul. 2013 (€38.52 Mil) and declined from Jul. 2013 (€38.52 Mil) to Oct. 2013 (€37.33 Mil).

Cangene's annual other long-term liabilities increased from Jul. 2011 (€4.47 Mil) to Jul. 2012 (€5.25 Mil) and increased from Jul. 2012 (€5.25 Mil) to Jul. 2013 (€38.52 Mil).

Cangene Other Long-Term Liabilities Historical Data

The historical data trend for Cangene's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Other Long-Term Liabilities Chart

Cangene Annual Data

Trend

Jul04

Jul05

Jul06

Jul07

Jul08

Jul09

Jul10

Jul11

Jul12

Jul13

Other Long-Term Liabilities

Get a 7-Day Free Trial

Cangene Quarterly Data
	Jan09	Apr09	Jul09	Oct09	Jan10	Apr10	Jul10	Oct10	Jan11	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Cangene Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Cangene Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Cangene's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cangene (FRA:YGE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.cangene.com

Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines